LY 264826Alternative Names: A 82846B; MM 45289; PA 450528
Latest Information Update: 08 Oct 2002
At a glance
- Originator Eli Lilly
- Class Antibacterials; Cephalosporins; Glycopeptides
- Mechanism of Action Cell wall inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Bacterial infections